CSF Levels of Hypocretin-1 (Orexin-A) Peak during Early Infancy in Humans
Authors:
Open Access
- 1 February 2012
- journal article
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 35 (2) , 187-191
Abstract
Study Objectives:. Hypocretin (orexin) is a unique neuropeptide involved in the consolidation of wakefulness and sleep. Although hypocretin-1 levels inKeywords
This publication has 55 references indexed in Scilit:
- Orexin/hypocretin plays a role in the response to physiological disequilibriumSleep Medicine Reviews, 2011
- Hypocretin-1 (orexin A) prevents the effects of hypoxia/hypercapnia and enhances the GABAergic pathway from the lateral paragigantocellular nucleus to cardiac vagal neurons in the nucleus ambiguusNeuroscience, 2011
- Direct and indirect control of orexin/hypocretin neurons by glycine receptorsThe Journal of Physiology, 2011
- Orexin/Hypocretin Modulates Response of Ventral Tegmental Dopamine Neurons to Prefrontal Activation: Diurnal InfluencesThe Journal of Neuroscience, 2010
- Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attentionBrain Research, 2010
- Orexin-A and Orexin-B During the Postnatal Development of the Rat BrainCellular and Molecular Neurobiology, 2009
- Adenosine Inhibits Activity of Hypocretin/Orexin Neurons by the A1 Receptor in the Lateral Hypothalamus: A Possible Sleep-Promoting EffectJournal of Neurophysiology, 2007
- Cholecystokinin Activates Orexin/Hypocretin Neurons through the Cholecystokinin A ReceptorJournal of Neuroscience, 2005
- Group III Metabotropic Glutamate Receptors Maintain Tonic Inhibition of Excitatory Synaptic Input to Hypocretin/Orexin NeuronsJournal of Neuroscience, 2004
- Postnatal Development of the EEG in the Dog‐IIIJournal of Small Animal Practice, 1967